---
title: "INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294711897.md"
description: "Halper Sadeh LLC is investigating whether Indivior Pharmaceuticals' board breached fiduciary duties in its merger with Supernus Pharmaceuticals. The firm questions if shareholders received a fair price and if the sales process was conflict-free. Shareholders are encouraged to contact the law firm to discuss potential legal action for increased consideration or relief."
datetime: "2026-08-03T14:47:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294711897.md)
  - [en](https://longbridge.com/en/news/294711897.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294711897.md)
generator: "portal-rs"
---

# INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Investor rights law firm Halper Sadeh LLC is currently looking into the merger between Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) and Supernus Pharmaceuticals, Inc., with the closing of the Proposed Transaction set to result in Indivior shareholders possessing around 56.5% of the combined entity. Shareholders of Indivior are advised by Halper Sadeh to explore further details on their rights and choices. They can reach out to Daniel Sadeh or Zachary Halper at no cost via (212) 763-0060 or sadeh@halpersa.

### Related Stocks

- [INDV.US](https://longbridge.com/en/quote/INDV.US.md)
- [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md)

## Related News & Research

- [SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders](https://longbridge.com/en/news/297401736.md)
- [Supernus Pharmaceuticals management attends Cantor Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297827223.md)
- [Faron Pharmaceuticals Ltd: Holding(s) In Company](https://longbridge.com/en/news/298025632.md)
- [Adarx Pharmaceuticals Announces Initial Public Offering Of Common Stock, SEC Filing](https://longbridge.com/en/news/298077949.md)
- [Heights Capital cuts Faron Pharmaceuticals voting rights to 20.25%](https://longbridge.com/en/news/298224452.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**